<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02663362</url>
  </required_header>
  <id_info>
    <org_study_id>TRIMD FH 306624</org_study_id>
    <nct_id>NCT02663362</nct_id>
  </id_info>
  <brief_title>Development and Validation of Multi-nuclear Magnetic Resonance Imaging and Spectroscopy for Whole Body Human Applications</brief_title>
  <acronym>MRS VALIDATION</acronym>
  <official_title>Development and Validation of Multi-nuclear Magnetic Resonance Imaging and Spectroscopy for Whole Body Human Applications</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Translational Research Institute for Metabolism and Diabetes, Florida</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Translational Research Institute for Metabolism and Diabetes, Florida</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to develop and refine the techniques for using magnetic
      resonance imaging and magnetic resonance spectroscopy to understand the composition and
      function of the human body
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>February 2012</start_date>
  <completion_date type="Anticipated">January 2027</completion_date>
  <primary_completion_date type="Anticipated">January 2026</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Whole body fat quantification</measure>
    <time_frame>1 hour</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Fat Microstructure</measure>
    <time_frame>1 hour</time_frame>
    <description>A high resolution image of the structure of fat tissue.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Flow high resolution imaging</measure>
    <time_frame>1 hour</time_frame>
    <description>Image of the movement of fluids in the area being imaged.</description>
  </other_outcome>
  <other_outcome>
    <measure>Intramyocellular fat quantification</measure>
    <time_frame>45 minutes</time_frame>
    <description>Use to determine the amount and types of fat inside muscle and liver.</description>
  </other_outcome>
  <other_outcome>
    <measure>Intrahepatic fat quantification</measure>
    <time_frame>45 minutes</time_frame>
    <description>A measure of the amount of fat in the liver.</description>
  </other_outcome>
  <enrollment type="Anticipated">250</enrollment>
  <condition>Human Body Composition</condition>
  <condition>Human Body Function</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>To evaluate the reproducibility of acquiring multi-nuclear data on a new 3T Philips Magnet</intervention_name>
    <description>Outside standard MR instrumentation there will be no interventions.</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        A healthy individual, who is willing and able to undergo MR imaging and spectroscopy for up
        to two hours at a time
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male or female

          -  Age 12 - 89

          -  Healthy (self assessed)

          -  Weight under 350lbs

          -  Able to walk 50 yards without stopping

          -  Able to travel to hospital for study visits

          -  Able to follow a 3-step command

          -  Able to remain in Magnetic Resonance (MR) scanner for up to 2 hours

        Exclusion Criteria:

          -  Have internal metal medical devices, including cardiac pacemakers, aortic or cerebral
             aneurysm clips, artificial heart valves, ferromagnetic implants, shrapnel, wire
             sutures, joint replacements, bone or joint pins/rods/screws, metal fragments in your
             eye, or non-removable jewelry such as rings.

          -  Are unwilling or unable to complete the imaging procedures for the duration of the MRI
             scan due to claustrophobia or other reason.

          -  Serious mental illness that might preclude subject's ability to comply with study
             treatment

          -  Life expectancy of less than 1 year

          -  Are pregnant or plan on becoming pregnant in the next 8 weeks.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>12 Years</minimum_age>
    <maximum_age>89 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Heather Cornnell, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Translational Research Institute for Metabolism and Diabetes</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Quianna Stokes-Washington</last_name>
    <phone>407-303-7100</phone>
    <email>tri@flhosp.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>Translational Research Institute for Metabolism and Diabetes</name>
      <address>
        <city>Orlando</city>
        <state>Florida</state>
        <zip>32804</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Quianna Stokes-Washington</last_name>
      <phone>407-303-7100</phone>
      <email>tri@flhosp.org</email>
    </contact>
    <investigator>
      <last_name>Heather Cornnell, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.tri-md.org</url>
    <description>Florida Hospital Translational Research Institute for Metabolism and Diabetes</description>
  </link>
  <reference>
    <citation>Tyler DJ, Hudsmith LE, Clarke K, Neubauer S, Robson MD. A comparison of cardiac (31)P MRS at 1.5 and 3 T. NMR Biomed. 2008 Oct;21(8):793-8. doi: 10.1002/nbm.1255.</citation>
    <PMID>18512846</PMID>
  </reference>
  <reference>
    <citation>Müller HP, Raudies F, Unrath A, Neumann H, Ludolph AC, Kassubek J. Quantification of human body fat tissue percentage by MRI. NMR Biomed. 2011 Jan;24(1):17-24. doi: 10.1002/nbm.1549.</citation>
    <PMID>20672389</PMID>
  </reference>
  <reference>
    <citation>Price RR, Allison J, Massoth RJ, Clarke GD, Drost DJ; NMR Task Group #8. Practical aspects of functional MRI (NMR Task Group #8). Med Phys. 2002 Aug;29(8):1892-912. Review.</citation>
    <PMID>12201436</PMID>
  </reference>
  <reference>
    <citation>Noseworthy MD, Bulte DP, Alfonsi J. BOLD magnetic resonance imaging of skeletal muscle. Semin Musculoskelet Radiol. 2003 Dec;7(4):307-15. Review.</citation>
    <PMID>14735429</PMID>
  </reference>
  <reference>
    <citation>Lebon V, Dufour S, Petersen KF, Ren J, Jucker BM, Slezak LA, Cline GW, Rothman DL, Shulman GI. Effect of triiodothyronine on mitochondrial energy coupling in human skeletal muscle. J Clin Invest. 2001 Sep;108(5):733-7.</citation>
    <PMID>11544279</PMID>
  </reference>
  <reference>
    <citation>Roser W, Beckmann N, Wiesmann U, Seelig J. Absolute quantification of the hepatic glycogen content in a patient with glycogen storage disease by 13C magnetic resonance spectroscopy. Magn Reson Imaging. 1996;14(10):1217-20.</citation>
    <PMID>9065913</PMID>
  </reference>
  <reference>
    <citation>Beckmann N, Fried R, Turkalj I, Seelig J, Keller U, Stalder G. Noninvasive observation of hepatic glycogen formation in man by 13C MRS after oral and intravenous glucose administration. Magn Reson Med. 1993 May;29(5):583-90.</citation>
    <PMID>8505893</PMID>
  </reference>
  <reference>
    <citation>van der Meer RW, Doornbos J, Kozerke S, Schär M, Bax JJ, Hammer S, Smit JW, Romijn JA, Diamant M, Rijzewijk LJ, de Roos A, Lamb HJ. Metabolic imaging of myocardial triglyceride content: reproducibility of 1H MR spectroscopy with respiratory navigator gating in volunteers. Radiology. 2007 Oct;245(1):251-7.</citation>
    <PMID>17885193</PMID>
  </reference>
  <reference>
    <citation>Schär M, Kozerke S, Boesiger P. Navigator gating and volume tracking for double-triggered cardiac proton spectroscopy at 3 Tesla. Magn Reson Med. 2004 Jun;51(6):1091-5.</citation>
    <PMID>15170826</PMID>
  </reference>
  <reference>
    <citation>Hudsmith LE, Tyler DJ, Emmanuel Y, Petersen SE, Francis JM, Watkins H, Clarke K, Robson MD, Neubauer S. (31)P cardiac magnetic resonance spectroscopy during leg exercise at 3 Tesla. Int J Cardiovasc Imaging. 2009 Dec;25(8):819-26. doi: 10.1007/s10554-009-9492-8. Epub 2009 Aug 21.</citation>
    <PMID>19697152</PMID>
  </reference>
  <reference>
    <citation>Shen W, Mao X, Wang Z, Punyanitya M, Heymsfield SB, Shungu DC. Measurement of intramyocellular lipid levels with 2-D magnetic resonance spectroscopic imaging at 1.5 T. Acta Diabetol. 2003 Oct;40 Suppl 1:S51-4.</citation>
    <PMID>14618433</PMID>
  </reference>
  <reference>
    <citation>Shen W, Mao X, Wolper C, Heshka S, Dashnaw S, Hirsch J, Heymsfield SB, Shungu DC. Reproducibility of single- and multi-voxel 1H MRS measurements of intramyocellular lipid in overweight and lean subjects under conditions of controlled dietary calorie and fat intake. NMR Biomed. 2008 Jun;21(5):498-506.</citation>
    <PMID>17955571</PMID>
  </reference>
  <reference>
    <citation>Larson-Meyer DE, Newcomer BR, Hunter GR. Influence of endurance running and recovery diet on intramyocellular lipid content in women: a 1H NMR study. Am J Physiol Endocrinol Metab. 2002 Jan;282(1):E95-E106.</citation>
    <PMID>11739089</PMID>
  </reference>
  <reference>
    <citation>Larson-Meyer DE, Smith SR, Heilbronn LK, Kelley DE, Ravussin E, Newcomer BR; Look AHEAD Adipose Research Group. Muscle-associated triglyceride measured by computed tomography and magnetic resonance spectroscopy. Obesity (Silver Spring). 2006 Jan;14(1):73-87.</citation>
    <PMID>16493125</PMID>
  </reference>
  <reference>
    <citation>Positano V, Gastaldelli A, Sironi AM, Santarelli MF, Lombardi M, Landini L. An accurate and robust method for unsupervised assessment of abdominal fat by MRI. J Magn Reson Imaging. 2004 Oct;20(4):684-9.</citation>
    <PMID>15390229</PMID>
  </reference>
  <reference>
    <citation>Smith SR, Lovejoy JC, Greenway F, Ryan D, deJonge L, de la Bretonne J, Volafova J, Bray GA. Contributions of total body fat, abdominal subcutaneous adipose tissue compartments, and visceral adipose tissue to the metabolic complications of obesity. Metabolism. 2001 Apr;50(4):425-35.</citation>
    <PMID>11288037</PMID>
  </reference>
  <reference>
    <citation>Larson-Meyer DE, Newcomer BR, Hunter GR, Joanisse DR, Weinsier RL, Bamman MM. Relation between in vivo and in vitro measurements of skeletal muscle oxidative metabolism. Muscle Nerve. 2001 Dec;24(12):1665-76.</citation>
    <PMID>11745976</PMID>
  </reference>
  <reference>
    <citation>Larson-Meyer DE, Newcomer BR, Hunter GR, Hetherington HP, Weinsier RL. 31P MRS measurement of mitochondrial function in skeletal muscle: reliability, force-level sensitivity and relation to whole body maximal oxygen uptake. NMR Biomed. 2000 Jan;13(1):14-27.</citation>
    <PMID>10668050</PMID>
  </reference>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 14, 2016</study_first_submitted>
  <study_first_submitted_qc>January 20, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 26, 2016</study_first_posted>
  <last_update_submitted>February 15, 2018</last_update_submitted>
  <last_update_submitted_qc>February 15, 2018</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 16, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>magnetic resonance imaging</keyword>
  <keyword>magnetic resonance spectroscopy</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

